Horndasch M, Culig Z

Department of Urology, Innsbruck Medical University, Innsbruck, Austria.

Therapy for advanced prostate cancer is only palliative and its improvement could be achieved by sensitization to pro-apoptotic agents to which resveratrol belongs. We investigated the interaction between the tumor-selective apoptosis inducer tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and suppressor of cytokine signaling (SOCS-3), an antiapoptotic molecule which is up-regulated in prostate cancer.Expression of SOCS-3 and TRAIL (death) receptors was determined by Western blot after treatment with TRAIL in prostate cancer cell lines. Binding of SOCS-3 to death receptors was investigated by immunoprecipitation. Apoptosis rate was determined by a propidium iodide assay after treatment by TRAIL and resveratrol.SOCS-3, whose expression was differentially regulated by TRAIL in androgen-insensitive prostate cell lines, binds to death receptor 4. Overexpression of SOCS-3 reduced apoptosis in TRAIL- and resveratrol-treated DU145 cells and SOCS-3 siRNA increased apoptosis in TRAIL-treated PC-3 and LNCaP-IL-6+ cells.Our results strongly suggest that SOCS-3 is one of the proteins which influence the ability of TRAIL and resveratrol to cause programmed cell death in prostate cancer.

Mesh Terms:
Antineoplastic Agents, Phytogenic, Apoptosis, Cell Line, Tumor, Down-Regulation, Humans, Male, Prostatic Neoplasms, RNA, Small Interfering, Receptors, TNF-Related Apoptosis-Inducing Ligand, Stilbenes, Suppressor of Cytokine Signaling Proteins, TNF-Related Apoptosis-Inducing Ligand, Up-Regulation

View in: Pubmed|Google Scholar

Download 1 Interactions For This Publication

144270

• Interactions (1)